My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  alliance managers  partners  partner  alliance manager  ecosystem  partnerships  The Rhythm of Business  partnership  Jan Twombly  biopharma  governance  Eli Lilly and Company  Strategic Alliance Magazine  Vantage Partners  IBM  IoT  ASAP BioPharma Conference  strategy  healthcare  NetApp  2015 ASAP Global Alliance Summit  Cisco  cloud  communication  digital transformation 

Making Adjustments: ASAP Global Alliance Summit Now in June!

Posted By Michael Leonetti, CSAP, Monday, March 9, 2020

We’ve all had the experience of an unexpected event that suddenly threw a wrench into our alliances or our lives. Depending on the nature of the event, its magnitude, and how close to home it hits, we generally do our best to understand how the landscape has changed, adjust to the implications, make accommodations, and move forward. Reality may defy our hopes and expectations, but we pick up the pieces, dust ourselves off, and keep getting up in the morning amid the now-altered environment.

So it is with the coronavirus, or COVID-19, whose effects worldwide have already proven serious. Our hearts go out to all those who have been directly affected by this virus, especially the families of those who have died from it around the globe. In addition, this contagious disease—and the fear of it—has already had a significant economic impact, including declines in business and vacation travel and the cancellation or postponement of a number of conventions, conferences, and trade shows in various industries. Most organizations have been forced to respond in some way, whether to shift events to alternative dates or from physical to virtual, to curtail travel to safeguard their people, or to try to limit the damage to their bottom line. Or all of the above.

We at ASAP have faced these challenges as well, resulting in the difficult decision to reschedule our Global Alliance Summit, which had been scheduled for next week, to June 23–25 in Tampa, Florida. In the great scheme of things this move may barely register, but for a member organization like ours, as you can imagine, it’s a big deal. Shifting the Summit to new dates has required a huge and immediate lift on the part of ASAP staff and board, which is ongoing as I write this.

The good news is, the show will go on! I’m very happy that we were able to secure the original conference venue, the Renaissance Tampa International Plaza Hotel, for our late-June dates. I’m even more pleased to report that at present, nearly 75 percent of our presenters, panelists, and moderators have confirmed that they’ll be there.

What this means is that we’ll still have a terrific program, as planned—a program that, as always, includes presentations by some of the alliance and partnering profession’s best and brightest minds and leading lights, including these:

  • A keynote presentation by Steve Steinhilber, global vice president, ecosystems and business development, at Equinix: “Creating Alliances and Digital Ecosystem Capabilities in an Increasingly Platform Enabled and Interconnected World.” Steve ran alliances at Cisco for a number of years, and while there authored the influential book Strategic Alliances: Three Ways to Make Them Work (2008). He was also among those interviewed for our Q1 2020 cover story in Strategic Alliance Quarterly on the rise and far-reaching effects of ecosystems in nearly every industry, and his insights into this important and growing area are sure to be valuable and applicable to any industry.
  • A fascinating panel moderated by Adam Kornetsky of Vantage Partners titled “Big Pharma M&A and Alliance Portfolios: What’s at the End of the Rainbow?” This interactive discussion will feature panelists including Mark Coflin, CSAP, vice president and head of global alliances at Takeda Pharmaceuticals; Dana Hughes, vice president of integration management and alliance management at Pfizer; and Jeffrey C. Hurley, senior director, GBD global alliance lead at Takeda. These longtime ASAP members will share their recent M&A experiences, provide insights into how alliance portfolios have been managed through the transaction process, and engage participants in sharing additional perspectives critical for unlocking and maximizing the full value of an alliance portfolio.
  • A presentation by Dan Rippey, director of engineering for Microsoft’s One Commercial Partner program, and Amit Sinha, chief customer officer and cofounder of WorkSpan, called “How the Microsoft Partner-to-Partner Program Is Disrupting the Way Technology Companies Are Leveraging the Power of Ecosystems for Business Growth, Customer Acquisition, and Gaining a Competitive Advantage.” With the rise of ecosystems has come the increasing deployment of partner-to-partner (P2P) programs, and Microsoft’s may be the largest on the planet, connecting partners directly with each other to deliver value to customers without Microsoft’s intervention. Powered by WorkSpan Ecosystem Cloud, this program increases profitability by selling solutions from one or more of Microsoft’s partners, achieving faster time-to-market by leveraging prebuilt joint solutions, closing larger deals, and reaching more customers by co-selling with other Microsoft partners for a bigger joint pipeline. This new model of partnering has wide applicability and Dan and Amit’s description of how it works is a must-hear.
  • Another terrific panel moderated by Jan Twombly, president of The Rhythm of Business, called “Biopharma Commercial Alliance Management Challenges.” Panelists will include Brooke Paige, CSAP, ASAP board chair and former vice president of alliance management at Pear Therapeutics; and David S. Thompson, CSAP, chief alliance officer at Eli Lilly and Company. In the long life of a successful biopharma alliance, the commercialization phase brings its own particular challenges and problems. This panel promises to be a lively discussion of such topics as how alliance managers deliver value in a commercial alliance, considerations for driving alignment in local geographies and at a corporate level, aspects of alliance governance to get right to maximize value, and much more.

I’m not indulging in hyperbole when I say that these are just a very few of the highlights. Again,  more than three-quarters of the original Summit agenda is planned  to remain intact—including preconference workshops, single-speaker presentations, illuminating panel discussions, and of course, valuable networking opportunities.

We know there are many factors governing decisions on where to travel and why—especially under current conditions. But we’re confident that even after shifting to the June dates, we’ll be fielding a stellar lineup at the Summit in Tampa—one you’ll want to be present for. If you haven’t registered yet and/or for whatever reason were uncertain about attending in March, you now have some extra time to decide.

Additionally, the Renaissance has set up a new block of rooms at our discounted rate of $219.00+ per night. To book your room for the new conference dates, please click on the link below:

https://www.marriott.com/event-reservations/reservation-link.mi?id=1583953400577&key=GRP&app=resvlink

Let’s all try to plan for normal again! Won’t you join us? I hope to see you in Tampa!

Tags:  alliances  Amit Sinha  biopharma  Brooke Paige  Dan Rippey  Dana Hughes  David Thompson  Ecosystems  Eli Lilly and Company  Equinix  Jan Twombly  Jeffrey Hurley  Mark Coflin  Microsoft  P2P  partners  Pfizer  Steve Steinhilber  Takeda  The Rhythm of Business  Vantage Partners  WorkSpan 

Share |
PermalinkComments (0)
 

A Lesson From the Whiz Kids: Change and Teams— ‘An Inevitable Combination’

Posted By Cynthia B. Hanson, Monday, July 22, 2019

My father, who recently passed away, worked for Ford Motor Company in its heyday. A 1950  graduate of Harvard Business School and a former Marine in World War II and the Korean War, he started working at  Ford in 1953 and eventually worked under Ford President Robert McNamara, who later became the longest-serving secretary of defense in United States history under Presidents  John F. Kennedy and Lyndon B. Johnson.

 

Ford Motor Company was losing millions in the post-  WWII era, but turned a corner through innovative production and management. Seeking new ways to succeed in a time of rapid change (sound familiar?), the company engaged in a unique partnership with a group of United States Air Force officers. Ford would provide the young men just out of the military with jobs and, in turn, the former officers would revamp the company. Disparagingly dubbed the “Quiz Kids” by fellow employees for their youthful questioning, they renamed themselves the “Whiz Kids.” As a manager in finance, production programming, sales, marketing, personnel, and technical and transportation operations, my father worked under their guidance to help reorganize Ford’s financial framework, redefine corporate culture, and contribute to automotive innovation.

 

After my father’s memorial service, I pored over the books in his library. You can tell a lot about a person from the books he or she reads. Based on the collective mix, he pursued self-education to the end, especially in the areas of business, history, leadership—and the art of fly fishing. The mix included tomes such as Doris Kearns Goodwin’s The Bully Pulpit and Nigel Hamilton’s The Mantle of Command. But what really caught my eye was an unassuming slip of a book: The Wisdom of Teams: Creating the High–Performance Organization, by Jon R. Katzenbach and Douglas K. Smith, Harvard Business School Press, 1993. As I paged through, I found only one sentence in the entire book underlined. In the chapter “Teams and Major Change: An Inevitable Combination,” the final sentence on Page 211 was highlighted: “It is no accident, then, that every single major change effort we know about has depended on teams.”

 

Through landmark business reconstruction and major wars my father had significant life experience leading and participating in successful teams. He must have come away from those experiences with an understanding of how major change is conjoined with well-organized teamwork. At age 93, the concept of digital transformation was a mystery to him, but the strategy necessary for such radical transformation was very familiar: Major change requires visionary leadership, well-orchestrated collaboration, and flexible innovation.

 

History can teach us a lot about successful collaboration. That connection came through at a ASAP BioPharma Conference in a session on “Alliance Management  Learnings from Great Leaders,” led by Harm-Jan Borgeld, head of alliance management at Merck KGaA;  David Thompson, CSAP, chief alliance officer at Eli Lilly and Company; Steven Twait, CSAP, vice president, alliance and integration management at AstraZeneca. The three alliance professionals probed questions about the “Big Three” WWII alliance led by Winston Churchill,  Franklin Delano Roosevelt, and Joseph Stalin—and how history’s lessons learned relate to today’s strategic alliances.

 

When designed and executed well, alliances can resolve conflict, innovate solutions, win wars, and rejuvenate flagging companies. Collaboration can even streamline services in the public sector and define the  workplace cultures of successful 21st century companies like Jazz Pharmaceuticals. For my father’s generation and for ours, it still comes down to inspired leaders and engaged executives who grapple with change by fostering a culture of teamwork and collaboration— and embrace partners along their journey forward. My dad would recognize this approach as “an inevitable combination.” 

Tags:  Alliances  AstraZeneca  Collaboration  David Thompson  Eli Lilly and Company  Harm-Jan Borgeld  Innovation  Jazz Pharmaceuticals  Merck KGaA  Steve Twait 

Share |
PermalinkComments (0)
 

Q2 2018 Strategic Alliance Magazine: The Culture of Jazz (Pharmaceuticals); a Massive Dutch Cross-agency Alliance; Award-winners—Past and Present; Three ASAP Fall Events

Posted By Cynthia B. Hanson, Wednesday, September 19, 2018
Updated: Monday, September 17, 2018

When the culture of a company really sings, it’s worth exploring the unifying elements. That’s what John W. DeWitt, ASAP Media and Strategic Alliance Magazine Editor and Publisher, explored in the Q2 2018 issue’s cover story, “Choose Culture First: How to Build a Collaborative Enterprise from the Ground Up—and Treat Every Partner Well.” DeWitt probes the underpinnings of Jazz Pharmaceutical in an interview with Cofounder and CEO Bruce Cozadd, and the company’s head of alliance management, Ann Kilrain. Culture, collaboration, and consistent partnering behaviors are integral to Jazz’s success, which is focused on sleep hematology/oncology solutions. “People judge you all the time, and what’s important is how you behave all the time,” says Kilrain during a captivating discussion that emphasizes how consistency and integrity are interwoven into the company culture. Also in this issue’s Up Front, “The Sound of Success,” President and CEO of ASAP, Michael Leonetti, reiterates that point with The Four Cs of Alliance Leadership: Communication, Culture, Collaboration, Compromise. In collaborative leadership, “leaders model their organization’s values and … can impact the culture of an organization,” he writes.  

A second cover story focuses on managing the collaboration of three big government agencies in The Netherlands. In “How an Alliance Matured from Chaos into Award-winning Order,” Diantha Croese, alliance manager at the Dutch Alliances on Data, and Menno Aardewijn, business consultant at the Dutch National SSA, discuss how they tamed a giant, unwieldy cross-agency collaboration between the Dutch IRA, Social Security Administration, and Statistics Netherlands. The management required incredible perseverance as well as “disruption, adap­tation, and overcoming sizable resistance,” and an intricate framework to establish cooperation and financial order between the agencies. Assigned the task of coordi­nating the collection of data about tax revenues, wages, benefits, and corresponding data for the Dutch gov­ernment, they streamlined financial data for the Dutch society while lowering administra­tive costs for employers and operating costs for the alliance partners.

Two other articles in this issue probe the question of what constitutes ASAP award-winning alliance behaviors. First is an article about the 2018 ASAP Alliance Excellence Awards, where seven companies won the four ASAP awards for remarkable accomplishments and exemplary conduct. The second article zeros in on the winner of the 2018 ASAP Alliance for Corporate Responsibility Award, which was presented this year to Cisco and Dimension Data for their celebration of 25 years of partnering with 25 altruistic service projects. The article highlights company employees and their voluntary contributions around the world, which range from education opportunities for girls in Sudan to community bicycles for school children in Thailand.

The Member Spotlight also focuses on the 2018 Individual Alliance Excellence Award winner Julphar in  “Breaking Boundaries in the Pharmaceutical Industry.” Along with pharmaceutical partner MSD, Julphar strategized to make a major difference in seven therapeutic areas for six countries in the Middle East and North Africa region. Julphar’s strategic alliance team consists of in­dividuals from diverse backgrounds whose combined skillsets and experience are viewed as critical to helping the company develop and sustain strong strategic alliances in a different area of the world to create the unique DUNES alliance.

Looking back, this issue also provides a roundup of the 2018 ASAP Global Alliance Summit in “The In-Demand, On-Demand World of Alliance Management, as Portrayed by the 2018 Summit Speakers.” The article captures the essential points of the keynote address and four plenary talks. Looking forward, “Circumnavigate the Globe this Fall With ASAP Conference Offerings” provides a synopsis of ASAP offerings this fall with a review of seminal topics for the three events: The BioPharma Conference, Tech Partner Forum, and European Alliance Summit.

For some hard-hitting findings, turn to Eli Lilly and Company’s Editorial Supplement “Common Value Inflection Points in Pharmaceutical Alliances.” Finding and understanding key inflection points can reveal a lot about your alliance and help alliance managers make good decisions, the article purports. It then does a deep dive into the topic with corroborating data and methodologies.

Finally, The Close relates a personal story about a former World War II Marine’s experience working at the Ford Motor Company in the 1950s during a time of great transition and innovation. “A Lesson From the Whiz Kids: Change and Teams‘An Inevitable Combination’” points out how teams have played an integral role in every major change throughout history. Whether political upheaval or disruption in business, it takes a combination of inspired leadership, engaged executives, collaboration, and a culture of teamwork to bring about a seismic shift. 

Tags:  2018 ASAP Alliance Excellence Awards  Ann Kilrain  ASAP BioPharma Conference  ASAP European Alliance Summit  ASAP Tech Partner Forum  Bruce Cozadd  Collaborative Enterprise  Culture First  Eli Lilly and Company  inflection points  Jazz Pharmaceutical  Julphar  MSD  Partnering Well  Strategic Alliance Magazine 

Share |
PermalinkComments (0)
 

‘You Give Me a Buck, and We Give You Back Three’: Pharma Partnering Leaders Discuss Roles—and the Value of Alliance Management

Posted By Genevieve Fraser, Friday, April 13, 2018
Updated: Wednesday, April 11, 2018

The evolving roles of alliance executives—and capturing the value of the alliance function—were among the many topics that emerged as during the Tuesday, March 27 leadership panel discussion, “Driving Alliance Excellence into the Future,” moderated by Andy Eibling, CSAP, former Covance vice president of alliances, at the ASAP 2018 Global Alliance Summit, “Propelling Partnering for the On-Demand World: New Perspectives + Proven Practices for Collaborative Business,” March 26-28, 2018. Fort Lauderdale, Florida, USA.

 

Pharma executives joining Eibling for the discussion included Casey Capparelli, global product general manager in oncology at Amgen; Nancy Griffin, CA-AM, vice president and head of alliance management, global business development & licensing at Novartis; Mark Noguchi, vice president and global head, alliances and asset management, at Roche; and David S. Thompson, CA-AM, chief alliance officer, Eli Lilly and Company. (Editor’s Note: See the forthcoming April 2018 edition of eSAM Plus for more coverage of this fascinating leadership discussion.)

 

When Eibling threw out the topic of alliance management’s role in acquisitions, mergers, and divestments, and business development and licensing, he noted, “You need to differentiate between a stop and start in terms of divestments. Divestments can be ongoing. Someone in the group manages the ongoing process.”

 

Capparelli: In Amgen that holds true for small acquisitions, but large complex acquisitions need to be managed separately.

 

Thompson: You need to look to someone else to run a large acquisition.

 

Eibling: There’s lots happening in the pharma world today, but will it continue?

 

Thompson: There are more and more partnerships. The trend grows and grows. Today each alliance manager is involved with 20 to 30 alliances. How do you manage ever increasing volume? It’s hard to predict if something will come to fruition.

 

Eibling: Let’s look at the role of the alliance manager, and how it has shifted between project management and alliance management. Alliance management and project management need to be connected at the hip and carve out space through the partnership management team. There are three roles in a partnership management team. The question is who drives those team meetings? Who is accountable? Does the project manager manage the success of the alliance?

 

Thompson: Most M&A integration gets done in 100 days. The work looks the same except it’s compressed. It takes 100 days to swallow an alliance. It’s at a pace you need in an M&A.

 

Capparelli: Deal making is a transactional approach, but building trust generates respect.

 

Griffin: You build an operating model in the core so that you build consistent capabilities.

 

Noguchi: The Roche alliance group is modeled after Lilly. The skill set is there but compressed.

 

Eibling: There’s a shift between deal makers and an alliance manager with a partner. No one understands the dynamics as well as an alliance manager. With ever expanding projects, it’s the alliance manager who understands motivations and how to construct the alliance and M&A deal.

“Let’s look at value,” Eibling said, wrapping up the panel discussion. “How do you capture the value of alliance management? How do you define value?” he asked Thompson.

“Alliances are not efficient but effective,” Thompson asserted.

 

“Fear is a great motivator,” he continued. “I’ve seen too many alliances go out of existence. They focused on relationship management but didn’t expand beyond that to the legal and business risk. That contributed to their demise. They didn’t feel valued in the organization. So, in times of hardship, they’re an easy target to eliminate,” he explained.

 

“We saw it happening and so became open about our model. We measure continuation. We are adjudicated by leadership. It’s valuable to talk about your own contributions. You get the [internal] client you’re supporting to agree based on what they think—what they value or don’t value. Is this a risk reduction or efficiency game? You build to be efficient but it’s the face-to-face that often counts.  As for monetizing the value of alliance management, it’s simple. You give me a buck, and we give you back three.”

Tags:  acquisitions  alliance management  alliance manager  Amgen  Andy Eibling  Casey Capparelli  David S. Thompson  Eli Lilly and Company  leadership  M&A  M&A integration  Mark Noguchi  Nancy Griffin  Novartis  partner  partnerships  Pharma executives  project manager  Roche 

Share |
PermalinkComments (0)
 

2018 ASAP Global Alliance Summit To Provide New Business Perspectives and Proven Leadership Practices

Posted By John W. DeWitt and Cynthia Hansen, Tuesday, December 19, 2017

Some 50-plus seasoned alliance managers and business insiders to share their know-how and valuable content in the form of sessions, workshops, talks, and panel discussions from 35-plus leading companies, educational institutions, and consultancies

The Association of Strategic Alliance Professionals (ASAP), an international association dedicated to the leadership and practice of alliance management, partnering, and business collaboration, announced the theme for the 2018 Global Alliance Summit: “Propelling Partnering for the On-Demand World: New Perspectives + Proven Practices for Collaborative Business,” to be held March 26-28 in Fort Lauderdale, Florida, USA. The largest international management education opportunity of its kind, participants have access to the latest trends in the profession from a range of leading industry thought leaders providing groundbreaking talks, practical workshops, and cutting-edge sessions.

The 2018 Summit particularly emphasizes programming for veteran alliance mangers that focuses on how to apply leading edge practices and seasoned know- how at a time of considerable change with increasing multi-industry partnering. The thought leaders representing numerous industry verticals will include influential c-level and senior executives from Fortune 100 and 500 companies.

The Summit will provide a rich mix of:

  • Fifty-plus facilitators, speakers, and panelists representing 35-plus industry-leading companies, educational institutions, and consultancies
  • Twenty-eight education sessions and in-conference workshops
  • Ten-plus hours of business development and networking opportunities
  • Eight different in-conference tracks
  • Six pre-conference workshops
  • A biopharma leadership panel session
  • The renowned ASAP Alliance Excellence Awards ceremony
  • Ample networking opportunities and an engaging roundtable session

Strong international participation in past Summits has created a diverse, global, cross-cultural climate with 25 percent attendance from countries such as Australia, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, India, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Poland, Russia, Saudi Arabia, Singapore, Spain, Sweden, Switzerland, and the United Kingdom.

The Summit is offering intensive leadership-related pre-conference workshops Monday, March 26, on topics such as ASAP’s newly launched in-house TE-AM Training, another on overcoming obstacles and conflict, leveraging the new ISO 44001 Collaborative Business Relationship Management Standard, Game Theory in strategic decision making and negotiations, Alliance Management 201 as a follow-up to the 101 session, and CA-AM exam preparation.

The event will start off Tuesday, March 27, with a timely keynote address by tech insider Tim Minahan, senior vice president of business strategy and chief marketing officer at Citrix. A leader in global marketing strategy and operations, he is responsible for securely deliver the world's most important apps and data. A tech eclectic, Minahan has served in a broad range of business leadership roles at leading enterprise software, cloud, and services firms. He is particularly adept at defining new markets and positioning companies to own them. He previously spearheaded SAP's successful transition to the cloud as CMO of the company's cloud and line-of-business unit. He joined SAP when the company acquired Ariba, where he was Ariba’s global CMO and senior vice president of business network strategy where he led the commercial strategy for the Ariba Network, the world's largest and most global business network. He also oversaw the design and execution of go-to-market programs and marketing initiatives to fuel Ariba’s growth as a leading cloud company. 

Before the day’s close, attendees will be privy to the winners of the ASAP Alliance Excellence Awards, a big favorite as companies are honored for their alliance capabilities in specific categories. The Summit will also highlight four scheduled plenaries from top-level speakers: two from pharma companies, including Mark Noguchi, Roche’s VP and global head of alliances and asset management and Lucinda Warren, VP, business development, neuroscience at Johnson & Johnson Innovation; two from high tech companies, including Russ Cobb, global VP of alliances and channels at SAS and Wayne Usie, senior vice president & chief market development officer at JDA Software. The remainder of the Summit will include a wide variety of sessions in eight different tracks that are geared toward enhancing alliance performance, such as the life sciences, tech, and leadership. The Summit will be strongly weighted toward higher-level alliance education, such as how to think strategically and how to drive collaborative leadership throughout an organization. A new, particularly strong leadership panel session will be comprised of biopharma executives David Thompson, CA-AM, CAO at Eli Lilly and Company; Mark Noguchi, VP and global head of alliances and asset management at Roche; Casey Caperelli, head of alliance and integration management at Amgen; Nancy Griffin, CA-AM, VP of alliances with Novartis.

Attendees can expect to receive strong content from recurring Summit rainmakers, such as:

  • Ben Gomes-Casseres, CSAP, Brandeis University and author of Remix Strategy partnered with Greg McGahan, PwC deals partner and alliances/joint venture practice leader, in their session “Alliances in Corporate Development: Back to the Future?”  
  • Stuart Kliman, a partner and head of alliance management practice at Vantage Partners with “Realizing the Value of Non-Traditional Partnerships in Pharma/Biotech and Technology”
  • Jan Twombly, CSAP, president, The Rhythm of Business, and Jeff Shuman, CSAP, principal, The Rhythm of Business, and professor of management, Bentley University with “Joint Development of Complex Solutions Requires Extreme Partnering”  
  • Joe Schramm, vice president strategic alliances, BeyondTrust, and Morgan Wheaton, senior director, global partner alliances & channels, JDA Software with Partnering with Change in a World of Ongoing Disruption”
  • Dr. Ard-Pieter de Man, CSAP, School of Business and Economics, Vrije Universiteit Amsterdam with “Building Your Collaborative Business Model”

Additionally, a mix of sessions will be providing strategic perspectives and management insights in a range of industries, such as:

  • “Architecting for Transformation: The Next Generation Partner Ecosystem,” by Russ Cobb, global vice president alliances and channels, SAS Institute, and Norma Watenpaugh, CSAP, founding principal, Phoenix Consulting Group
  • “How to Optimize Value and Gracefully End Alliance Relationships,” by Jeff Hurley, CA-AM, alliance management director, Eli Lilly and Company, and Ron McRae, CSAP, director of alliance management, Janssen Biotech
  • “Alliance Management: A Growing, Enterprise-wide Activity,” by Karen Denton, CA-AM, alliance management director, BD&L alliance management, Bayer Pharmaceuticals, and Christoph Huwe, CA-AM, PhD, strategic alliance manager therapeutics, global external innovation & alliances, Bayer Pharmaceuticals
  • “Centralized vs. Decentralized Alliance Organizations: How to Survive and Thrive in Both Ecosystems!”, by Tony DeSpirito, CSAP, vice president/general manager of operation services, Schneider Electric, and Scott San Antonio, CA-AM, global director for IoT and edge compute alliances, Schneider Electric

This is a representative selection of what’s on the docket. For more information about the Summit keynote, agenda, sessions, workshops, and other programming, go to: http://asapsummit.org/.

Tags:  Amgen  Bayer  Casey Caperelli  Cindy Warren  Citrix  Eli Lilly and Company  Janssen Biotech  Jeff Hurley  Joe Schramm  Johnson and Johnson Innovation  Karen Denton  Mark Noguchi  Nancy Griffin  Novartis  Roche  Ron McRae  Russ Cobb  SAS Institute  Schneider Electric  Tim Minahan  Tony DeSpirito  Wayne Usie 

Share |
PermalinkComments (0)
 
Page 1 of 4
1  |  2  |  3  |  4
For more information email us at info@strategic-alliances.org or call +1-781-562-1630